Baker Avenue Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.9M Buy
25,996
+4,508
+21% +$4.57M 0.54% 43
2025
Q4
$23.1M Sell
21,488
-899
-4% -$860K 0.53% 48
2025
Q3
$17.1M Buy
22,387
+4,203
+23% +$3.13M 0.41% 63
2025
Q2
$14.2M Sell
18,184
-551
-3% -$428K 0.4% 65
2025
Q1
$15.5M Buy
18,735
+2,864
+18% +$2.38M 0.48% 55
2024
Q4
$12.3M Buy
15,871
+62
+0.4% +$51.3K 0.38% 59
2024
Q3
$14M Buy
15,809
+3,310
+26% +$2.98M 0.44% 57
2024
Q2
$11.3M Sell
12,499
-275
-2% -$220K 0.39% 60
2024
Q1
$9.94M Buy
12,774
+269
+2% +$191K 0.39% 61
2023
Q4
$7.29M Buy
12,505
+810
+7% +$473K 0.32% 71
2023
Q3
$6.28M Buy
11,695
+9,430
+416% +$4.86M 0.31% 70
2023
Q2
$1.06M Buy
2,265
+1,202
+113% +$504K 0.05% 184
2023
Q1
$365K Sell
1,063
-1,189
-53% -$401K 0.02% 286
2022
Q4
$824K Sell
2,252
-124
-5% -$44K 0.05% 186
2022
Q3
$768K Buy
2,376
+1,116
+89% +$354K 0.05% 188
2022
Q2
$408K Sell
1,260
-92
-7% -$27.6K 0.03% 236
2022
Q1
$387K Sell
1,352
-633
-32% -$163K 0.02% 244
2021
Q4
$548K Buy
1,985
+776
+64% +$197K 0.03% 214
2021
Q3
$279K Buy
1,209
+33
+3% +$8.14K 0.02% 224
2021
Q2
$269K Buy
1,176
+41
+4% +$8.24K 0.02% 218
2021
Q1
$212K Buy
+1,135
New +$222K 0.01% 231

Other funds holding LLY

Baker Avenue Asset Management's LLY Position: Q1 2026 in Review

Baker Avenue Asset Management increased its Eli Lilly (LLY) stake by 21% in Q1 2026, buying an estimated $4.57M and bringing the position to 25,996 shares worth $23.9M. The position accounts for 0.54% of the portfolio, ranked #43.

Baker Avenue Asset Management first reported a position in LLY in Q1 2021 and has held it in 21 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Baker Avenue Asset Management held 25,996 shares of Eli Lilly worth $23.9M as of Q1 2026.
  • Baker Avenue Asset Management bought 4,508 Eli Lilly shares in Q1 2026, an estimated $4.57M.
  • Eli Lilly made up 0.54% of Baker Avenue Asset Management's portfolio in Q1 2026, its #43 holding.
  • Baker Avenue Asset Management first reported a position in Eli Lilly in Q1 2021 and has held it in 21 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Baker Avenue Asset Management's 13F filing for Q1 2026, filed 12 May 2026.